VNRX VOLITIONRX LTD revenue, earnings and financials
For the quarter ended June 30, 2026, VOLITIONRX LTD reported revenue of $399K (down 2.0% from a year earlier), net income of −$7.33M and diluted EPS of −$0.85; over the last four quarters revenue was $2.46M and net income −$25.6M; for the fiscal year ended December 2025 revenue was $1.73M, up 40.0% on the year before.
VNRX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.73M, gross profit n/a, operating income −$21.7M, net income −$23.4M (margin -1352.2%), EPS n/a
- Fiscal year ended Dec 2024: revenue $1.23M, gross profit n/a, operating income −$27.0M, net income −$27.0M (margin -2186.3%), EPS −$0.31
- Fiscal year ended Dec 2023: revenue $775K, gross profit n/a, operating income −$36.0M, net income −$35.7M (margin -4601.7%), EPS −$0.50
- Fiscal year ended Dec 2022: revenue $306K, gross profit n/a, operating income −$31.8M, net income −$30.6M (margin -9986.7%), EPS n/a
- Fiscal year ended Dec 2021: revenue $90.0K, gross profit n/a, operating income −$28.3M, net income −$27.0M (margin -29977.0%), EPS −$0.51
VNRX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $399K (down 2.0% year over year), net income −$7.33M, EPS −$0.85
- Quarter ended Mar 31, 2026: revenue $985K (up 299.8% year over year), net income −$6.66M, EPS −$0.97
- Quarter ended Dec 31, 2025 (from the annual report): revenue $447K (up 133.2% year over year), net income −$6.27M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $627K (up 32.2% year over year), net income −$5.38M, EPS −$0.05
- Quarter ended Jun 30, 2025: revenue $407K (up 2.8% year over year), net income −$6.28M, EPS −$1.22
- Quarter ended Mar 31, 2025: revenue $246K (up 43.6% year over year), net income −$5.42M, EPS −$1.12
- Quarter ended Dec 31, 2024 (from the annual report): revenue $192K (down 21.4% year over year), net income −$5.79M, EPS −$0.06
- Quarter ended Sep 30, 2024: revenue $475K (up 187.2% year over year), net income −$5.82M, EPS −$0.07
- Quarter ended Jun 30, 2024: revenue $396K (up 83.0% year over year), net income −$6.99M, EPS −$0.08
- Quarter ended Mar 31, 2024: revenue $172K (up 14.5% year over year), net income −$8.37M, EPS −$0.10
- Quarter ended Dec 31, 2023 (from the annual report): revenue $244K (up 103.8% year over year), net income −$8.80M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $165K (up 405.0% year over year), net income −$8.45M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $216K (up 444.1% year over year), net income −$9.55M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $150K (up 31.2% year over year), net income −$8.87M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue $120K (up 740.7% year over year), net income −$7.34M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $32.7K (up 28.4% year over year), net income −$7.81M, EPS n/a
- Quarter ended Jun 30, 2022: revenue $39.8K (up 60.4% year over year), net income −$7.73M, EPS n/a
- Quarter ended Mar 31, 2022: revenue $114K (up 347.4% year over year), net income −$7.72M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $14.2K, net income −$8.11M, EPS −$0.16
- Quarter ended Sep 30, 2021: revenue $25.5K, net income −$7.18M, EPS −$0.13
VNRX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$19.7M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$25.9M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow −$18.1M, share buybacks $31.8K
- Fiscal year ended Dec 2022: operating cash flow −$15.3M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow −$20.9M, share buybacks n/a
VNRX balance sheet
- Jun 30, 2026: cash $2.80M, total assets $8.30M, total liabilities $41.8M, shareholders' equity −$32.2M, long-term debt $5.98M
- Mar 31, 2026: cash n/a, total assets $9.04M, total liabilities $42.4M, shareholders' equity −$32.0M, long-term debt $6.35M
- Dec 31, 2025: cash $1.12M, total assets $6.90M, total liabilities $42.5M, shareholders' equity −$34.2M, long-term debt $5.82M
- Sep 30, 2025: cash $200K, total assets $6.45M, total liabilities $42.4M, shareholders' equity −$34.6M, long-term debt $5.57M
- Jun 30, 2025: cash $2.30M, total assets $8.70M, total liabilities $41.8M, shareholders' equity −$31.8M, long-term debt $5.77M
- Mar 31, 2025: cash $2.60M, total assets $8.52M, total liabilities $37.5M, shareholders' equity −$27.8M, long-term debt $5.53M
- Dec 31, 2024: cash $3.26M, total assets $9.40M, total liabilities $35.5M, shareholders' equity −$24.9M, long-term debt $3.95M
- Sep 30, 2024: cash n/a, total assets $12.7M, total liabilities $35.3M, shareholders' equity −$21.5M, long-term debt $3.84M
What is VNRX's revenue?
VOLITIONRX LTD reported $2.46M of revenue over its last four quarters, through June 30, 2026.
Is VNRX profitable?
No. VOLITIONRX LTD lost $25.6M over the last four quarters.